-
1
-
-
77649091668
-
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus
-
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
-
(2007)
Endocr Pract
, vol.13
, Issue.SUPPL. 1
, pp. 1-68
-
-
-
2
-
-
64749100501
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32(1):193-203
-
(2009)
Diabetes Care
, vol.32
, Issue.1
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
3
-
-
0034117810
-
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo
-
Heinemann L, Linkeschova R, Rave K, et al. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23(5):644-649 (Pubitemid 30321545)
-
(2000)
Diabetes Care
, vol.23
, Issue.5
, pp. 644-649
-
-
Heinemann, L.1
Linkeschova, R.2
Rave, K.3
Hompesch, B.4
Sedlak, M.5
Heise, T.6
-
4
-
-
0033661254
-
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
-
Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000; 49(12):2142-2148
-
(2000)
Diabetes
, vol.49
, Issue.12
, pp. 2142-2148
-
-
Lepore, M.1
Pampanelli, S.2
Fanelli, C.3
-
5
-
-
0142138134
-
Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin
-
DOI 10.1016/S1056-8727(03)00076-X
-
Kilo C, Mezitis N, Jain R, et al. Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin. J Diabetes Complications 2003;17(6):307-313 (Pubitemid 37315939)
-
(2003)
Journal of Diabetes and Its Complications
, vol.17
, Issue.6
, pp. 307-313
-
-
Kilo, C.1
Mezitis, N.2
Jain, R.3
Mersey, J.4
McGill, J.5
Raskin, P.6
-
6
-
-
33646014162
-
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
-
Garber AJ, Wahlen J, Wahl T, et al. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006;8(1):58-66
-
(2006)
Diabetes Obes Metab
, vol.8
, Issue.1
, pp. 58-66
-
-
Garber, A.J.1
Wahlen, J.2
Wahl, T.3
-
7
-
-
0034694856
-
Ethical principles for medical research involving human subjects
-
World Medical Association Declaration of Helsinki
-
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA 2000;284(23):3043-3045
-
(2000)
JAMA
, vol.284
, Issue.23
, pp. 3043-3045
-
-
-
9
-
-
33645097582
-
Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience
-
Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15(3):481-491
-
(2006)
Qual Life Res
, vol.15
, Issue.3
, pp. 481-491
-
-
Brod, M.1
Skovlund, S.E.2
Wittrup-Jensen, K.U.3
-
10
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321(7258):405-412 (Pubitemid 30609442)
-
(2000)
British Medical Journal
, vol.321
, Issue.7258
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
Hadden, D.7
Turner, R.C.8
Holman, R.R.9
-
11
-
-
33845317568
-
Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride
-
DOI 10.1055/s-2006-949655
-
Kann PH, Wascher T, Zackova V, et al. Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus oncedaily insulin glargine plus glimepiride. Exp Clin Endocrinol Diabetes 2006;114(9):527-532 (Pubitemid 44870902)
-
(2006)
Experimental and Clinical Endocrinology and Diabetes
, vol.114
, Issue.9
, pp. 527-532
-
-
Kann, P.H.1
Wascher, T.2
Zackova, V.3
Moeller, J.4
Medding, J.5
Szocs, A.6
Mokan, M.7
Mrevlje, F.8
Regulski, M.9
-
12
-
-
12844265257
-
Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
-
DOI 10.2337/diacare.28.2.260
-
Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005;28(2):260-265 (Pubitemid 40170923)
-
(2005)
Diabetes Care
, vol.28
, Issue.2
, pp. 260-265
-
-
Raskin, P.1
Allen, E.2
Hollander, P.3
Lewin, A.4
Gabbay, R.A.5
Hu, P.6
Bode, B.7
Garber, A.8
-
13
-
-
66149131064
-
Diabetes in Asia: Epidemiology, risk factors, and pathophysiology
-
Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301(20):2129-2140
-
(2009)
JAMA
, vol.301
, Issue.20
, pp. 2129-2140
-
-
Chan, J.C.1
Malik, V.2
Jia, W.3
-
15
-
-
39049105019
-
A randomised, 52-week, treat-totarget trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
-
Rosenstock J, Davies M, Home PD, et al. A randomised, 52-week, treat-totarget trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia 2008;51(3):408-416
-
(2008)
Diabetologia
, vol.51
, Issue.3
, pp. 408-416
-
-
Rosenstock, J.1
Davies, M.2
Home, P.D.3
-
16
-
-
0242269000
-
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
DOI 10.2337/diacare.26.11.3080
-
Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26(11):3080-3086 (Pubitemid 37339502)
-
(2003)
Diabetes Care
, vol.26
, Issue.11
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
17
-
-
0021878973
-
Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin
-
Pramming S, Thorsteinsson B, Bendtson I, et al. Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Br Med J (Clin Res Ed) 1985;291(6492):376-379 (Pubitemid 15012998)
-
(1985)
British Medical Journal
, vol.291
, Issue.6492
, pp. 376-379
-
-
Pramming, S.1
Thorsteinsson, B.2
Bendtson, I.3
|